A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma
- 10 February 2006
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 97 (3) , 644-648
Abstract
OBJECTIVE: To assess the immunoexpression of p21 and p27 proteins in consecutive areas of benign glands, prostatic intraepithelial neoplasia (PIN) and prostate adenocarcinoma. PATIENTS AND METHODS: Tissue from 91 patients who had a radical prostatectomy was assessed by immunohistochemistry to evaluate the expression of p21 and p27 in adjacent areas of benign glands, PIN and prostate adenocarcinoma. The results were correlated with various clinicopathological variables, e.g. age, total prostate‐specific antigen level, tumour stage, Gleason score, surgical margin involvement, extraprostatic extension, seminal vesicle invasion, and perineural invasion. RESULTS: The p27 score in PIN was lower than that in benign glands ( P = 0.04) but there was no significant difference between the scores for PIN and tumour. By contrast, p21 expression was almost undetectable in benign glands, although there was substantially more in PIN and tumour ( P < 0.01). Some patients had no expression of p21 in tumour tissue, and had lower p21 scores in benign glands and PIN areas ( P < 0.05). Interestingly, these patients had a lower frequency of negative prognostic variables. The tumour p21 score was higher in patients with extraprostatic extension ( P = 0.045) and tumour p27 expression was inversely correlated with seminal vesicle invasion ( P = 0.028). Tumour and PIN p27 expression appeared to decrease with advancing age ( P = 0.008 and 0.012, respectively). CONCLUSION: Higher p21 and lower p27 expression is correlated with adverse prognostic factors. The decline in p27 with advancing age in tumour and PIN areas may be a possible explanation of the greater frequency of prostate adenocarcinoma in older men. A p21‐negative tumour subgroup with a lower frequency of adverse prognostic factors was identified, which needs to be further explored.Keywords
This publication has 23 references indexed in Scilit:
- Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomyThe Prostate, 2003
- Expression and Prognostic Value of the Cell-cycle Regulatory Proteins, Rb, p16MTS1, p21WAF1, p27KIP1, Cyclin E, and Cyclin D2, in Ovarian CancerInternational Journal of Gynecological Pathology, 2003
- Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomasHuman Pathology, 2001
- PROGNOSTIC VALUE OF CELL CYCLE PROTEINS p27 kip1 AND MIB-1, AND THE CELL ADHESION PROTEIN CD44s IN SURGICALLY TREATED PATIENTS WITH PROSTATE CANCERJournal of Urology, 2000
- Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patientsBritish Journal of Cancer, 1999
- p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human CancersThe American Journal of Pathology, 1999
- The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human CancerAnnual Review of Medicine, 1999
- Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significanceHuman Pathology, 1998
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993